D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot and D-serine and Cognitive Remediation in Schizophrenia: Double Blind

Trial Profile

D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot and D-serine and Cognitive Remediation in Schizophrenia: Double Blind

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2015

At a glance

  • Drugs D-serine (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Mar 2015 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 14 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top